| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 4 |
| 1 | AMBRISENTAN | 3 |
| 2 | PANTOPRAZOLE | 3 |
| 3 | SILDENAFIL CITRATE | 3 |
| 4 | TADALAFIL | 3 |
| 5 | ADALIMUMAB | 2 |
| 6 | ALTEPLASE | 2 |
| 7 | FAMOTIDINE | 2 |
| 8 | FUROSEMIDE | 2 |
| 9 | LORATADINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 1 | COLESEVELAM HYDROCHLORIDE | 1 | 0.0009 |
| 2 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 3 | IDURSULFASE | 1 | 0.0003 |
| 4 | MIDODRINE HYDROCHLORIDE | 1 | 0.0002 |
| 5 | LOTEPREDNOL ETABONATE | 1 | 0.0002 |
| 6 | ALTEPLASE | 2 | 0.0001 |
| 7 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 1 | 0.0001 |
| 8 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 9 | BUPIVACAINE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 5 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Prostacycline Vasodilator [EPC] | 4 | 0.0000 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 8 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 9 | Aromatic Amino Acid [EPC] | 1 | 0.0000 |